Dualid is an anorexic drug that contains the active ingredient in anfepmone.
This oral drug inhibits appetite, being indicated for the treatment of obesity, but to cause weight loss, the drug must be associated with diets, physical exercises and behavioral changes.
Dualid acts on the brain, precisely in the area of satiety, thus suppressing appetite.
Obesity.
Gastrointestinal: changes in taste; abdominal pain dry mouth Diarrhea constipation; Vomiting
Cardiovascular: cardiac arrhythmia; Increased heart rate Increased or decreased blood pressure Palpitations.
Central nervous system: reduced concentration; Weakness Skull pain; irritability Depression Personality changes dizziness Nervousness.
Dermatological: welts; Itching
Eye: blurred vision; Blurry vision.
Other: breast augmentation; impotence chest pain; irregular menstruation; urinary disorder.
Risk of pregnancy B; Women who breastfeed; Chronic alcohol atherosclerosis; heart disease; glaucoma; Brain ischemia; High-pressure agitation; hyperthyroidism; Uremia of drug users; psychosis (schizophrenia); children under the age of 16.
Orally
(1 hour before meals)
Adult